Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Drug interaction
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Based on metabolism === [[File:CYP2C9 1OG2.png|thumb|200px|Diagram of cytochrome P450 [[CYP2C9|isoenzyme 2C9]] with the [[heme|haem]] group in the centre of the enzyme.]] Many drug interactions are due to alterations in [[drug metabolism]].<ref name=GENENG15June2008>{{cite news | author=Elizabeth Lipp | title=Tackling Drug-Interaction Issues Early On | url=http://www.genengnews.com/articles/chitem.aspx?aid=2509 | work=[[Genetic Engineering & Biotechnology News]] | publisher=[[Mary Ann Liebert, Inc.]] | pages=14, 16, 18, 20 | date=2008-06-15 | access-date=2008-07-06 | quote=(subtitle) Researchers explore a number of strategies to better predict drug responses in the clinic }}</ref> Further, human drug-metabolizing enzymes are typically activated through the engagement of [[nuclear receptor]]s.<ref name=GENENG15June2008/> One notable system involved in metabolic drug interactions is the enzyme system comprising the [[cytochrome P450 oxidase]]s. ==== CYP450 ==== [[Cytochrome P450]] is a very large family of [[hemeprotein|haemoprotein]]s (hemoproteins) that are characterized by their [[enzyme|enzymatic]] activity and their role in the metabolism of a large number of drugs.<ref>{{GoldBookRef|title=cytochrome P450|file=CT06821}} {{cite journal | vauthors = Danielson PB | title = The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans | journal = Current Drug Metabolism | volume = 3 | issue = 6 | pages = 561–97 | date = December 2002 | pmid = 12369887 | doi = 10.2174/1389200023337054 }}</ref> Of the various families that are present in humans, the most interesting in this respect are the 1, 2 and 3, and the most important enzymes are [[CYP1A2]], [[CYP2C9]], [[CYP2C19]], [[CYP2D6]], [[CYP2E1]] and [[CYP3A4]].<ref name="Nelson">Nelson D (2003). [http://drnelson.utmem.edu/P450lect.html Cytochrome P450s in humans] {{webarchive |url=https://web.archive.org/web/20090710050953/http://drnelson.utmem.edu/P450lect.html |date=July 10, 2009 }}. Consulted 9 May 2005.</ref> The majority of the enzymes are also involved in the metabolism of [[endogenous]] substances, such as [[steroid]]s or [[sex hormones]], which is also important should there be interference with these substances. The function of the enzymes can either be stimulated ([[enzyme induction]]) or inhibited ([[enzyme inhibition]]). ==== Through enzymatic inhibition and induction ==== If a drug is metabolized by a CYP450 enzyme and drug B blocks the activity of these enzymes, it can lead to pharmacokinetic alterations. A. This alteration results in drug A remaining in the bloodstream for an extended duration, and eventually increase in concentration.{{Citation needed|date=November 2023}} In some instances, the inhibition may reduce the therapeutic effect, if instead the metabolites of the drug is responsible for the effect.{{Citation needed|date=November 2023}} Compounds that increase the efficiency of the enzymes, on the other hand, may have the opposite effect and increase the rate of metabolism. ==== Examples of metabolism-based interactions ==== An example of this is shown in the following table for the [[CYP1A2]] enzyme, showing the substrates (drugs metabolized by this enzyme) and some inductors and inhibitors of its activity:<ref name="Nelson" /> {| class="wikitable" style="margin:1em auto;" width="100%" |- | colspan="3" style="text-align:center;" | '''Drugs related to CYP1A2''' |- ! Substrates !! Inhibitors !! Inductors |- style="vertical-align: top;" | * [[Caffeine]] * [[Theophylline]] * [[Phenacetin]] * [[Clomipramine]] * [[Clozapine]] * [[Thioridazine]] || * [[Omeprazole]] * [[Nicotine]] * [[Cimetidine]] * [[Ciprofloxacin]] || * [[Phenobarbital]] * [[Fluvoxamine]] * [[Venlafaxine]] * [[Ticlopidine]] |} Some foods also act as inductors or inhibitors of enzymatic activity. The following table shows the most common: {| class="wikitable" style="margin:1em auto;" width=100% |- |colspan="3" style="text-align:center;"| Foods and their influence on drug metabolism<ref>{{cite journal | vauthors = Bailey DG, Malcolm J, Arnold O, Spence JD | title = Grapefruit juice-drug interactions | journal = British Journal of Clinical Pharmacology | volume = 46 | issue = 2 | pages = 101–10 | date = August 1998 | pmid = 9723817 | pmc = 1873672 | doi = 10.1046/j.1365-2125.1998.00764.x }}<br/>Comment in: {{cite journal | vauthors = Mouly S, Paine MF | title = Effect of grapefruit juice on the disposition of omeprazole | journal = British Journal of Clinical Pharmacology | volume = 52 | issue = 2 | pages = 216–7 | date = August 2001 | pmid = 11488783 | pmc = 2014525 | doi = 10.1111/j.1365-2125.1978.00999.pp.x }}{{Dead link|date=January 2019 |bot=InternetArchiveBot |fix-attempted=yes }}</ref><ref name="Marduga" /><ref>{{cite journal |author=Covarrubias-Gómez, A. |title=¿Qué se auto-administra su paciente?: Interacciones farmacológicas de la medicina herbal |journal=Revista Mexicana de Anestesiología |volume=28 |issue=1 |pages=32–42 |date=January–March 2005 |url=http://www.medigraphic.com/espanol/e-htms/e-rma/e-cma2005/e-cma05-1/em-cma051f.htm |archive-url=https://archive.today/20120629232743/http://www.medigraphic.com/espanol/e-htms/e-rma/e-cma2005/e-cma05-1/em-cma051f.htm |url-status=dead |archive-date=2012-06-29 |display-authors=etal }}</ref> |- ! Food !! Mechanism !! Drugs affected |- | * [[Avocado]] * [[Brassicaceae|Brassica]]s (Brussels sprouts, broccoli, cabbage) |Enzymatic inductor |[[Acenocoumarol]], [[warfarin]] |- |[[Grapefruit]] juice |Enzymatic inhibition | * [[Calcium channel blocker]]s: [[nifedipine]], [[felodipine]], [[nimodipine]], [[amlodipine]] * [[Cyclosporine]], [[tacrolimus]] * [[Terfenadine]], [[astemizole]] * [[Cisapride]], [[pimozide]] * [[Carbamazepine]], [[saquinavir]], [[midazolam]], [[alprazolam]], [[triazolam]] {{main|Grapefruit drug interactions}} |- |[[Soybean|Soya]] |Enzymatic inhibition |[[Clozapine]], [[haloperidol]], [[olanzapine]], [[caffeine]], [[Non-steroidal anti-inflammatory drug|NSAIDs]], [[phenytoin]], [[zafirlukast]], [[warfarin]] |- |[[Garlic]] |Increases antiplatelet activity | * [[Anticoagulant]]s * [[Non-steroidal anti-inflammatory drug|NSAIDs]], [[acetylsalicylic acid]] |- |[[Ginseng]] |To be determined |[[Warfarin]], [[heparin]], [[aspirin]] and [[Non-steroidal anti-inflammatory drug|NSAIDs]] |- |''[[Ginkgo biloba]]'' |Strong inhibitor of platelet aggregation factor |[[Warfarin]], [[aspirin]] and [[Non-steroidal anti-inflammatory drug|NSAIDs]] |- |''[[Hypericum perforatum]]'' (St John's wort) |Enzymatic inductor (CYP450) |Warfarin, [[digoxin]], [[theophylline]], cyclosporine, [[phenytoin]] and antiretrovirals |- |[[Ephedra (medicine)|Ephedra]] |Receptor level agonist |[[MAOI]], central nervous system stimulants, alkaloids [[ergotamine]]s and [[xanthine]]s |- |Kava (''Piper methysticum'') |Unknown |[[Levodopa]] |- |[[Ginger]] |Inhibits thromboxane synthetase (''in vitro'') |Anticoagulants |- |Chamomile |Unknown |[[Benzodiazepine]]s, [[barbiturate]]s and [[opioid]]s |- |[[Crataegus|Hawthorn]] |Unknown |Beta-adrenergic antagonists, [[cisapride]], digoxin, [[quinidine]] |}
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)